AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/coms2/summary_0286-12472897_ITM" title="Facts and information about Sunitinib OK'd, ups survival in GI cancer.">Sunitinib OK'd, ups survival in GI cancer.</a>

Close Set up an RSS feed that alerts you when new articles from UPI Health Business are available.

Frequently asked questions about RSS feeds

Sunitinib OK'd, ups survival in GI cancer.

UPI Health Business

| January 27, 2006 | COPYRIGHT 2005 United Press International. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Byline: ED SUSMAN

SAN FRANCISCO, Jan. 26 (UPI) -- A just-approved oral drug that targets the molecular mechanisms of cancer extends the lives of some gastric-cancer patients whose disease has progressed due to failures of other treatments.

Sunitinib (Sutent, Pfizer, also known as SU11248) appears to control the spread of gastrointestinal stromal tumors, or GISTs, after another drug -- imatinib (Gleevec) loses effectiveness.

The Food and Drug Administration approved the therapy Thursday for that use as well as for advanced kidney cancer.

"Although GIST tumors are uncommon, this study is important because it shows that we can create drugs…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


Gleevec may be effective for mucosal melanomas.(Cutaneous Oncology): Magazine article from: Skin & Allergy News Goldman, Erik October 1, 2007 700+ words
NEW YORK -- Is Gleevec a reasonable therapeutic choice...summer academy 2007 conference. Gleevec (imatinib mesylate) will probably...at the University of California, San Francisco. Gleevec was the breakthrough agent representing...


Researchers discover why Gleevec-type drugs control, but do not eradicate...: Newspaper article from: Biotech Week December 24, 2008 700+ words
...revolutionary targeted cancer pill, Gleevec, or similar therapies in that...Society of Hematology conference in San Francisco. Gleevec, also called imatinib, works...grow uncontrollably. However, Gleevec also affects other proteins...


Gleevec* (Formerly STI571) - an Experimental Cancer Agent From Novartis...: Press release article from: PR Newswire May 8, 2001 700+ words
...key ASCO presentations for Gleevec as well as other Novartis...Note: The spelling for "Gleevec" was changed from "Glivec...Moscone Convention Center San Francisco, CA Key Highlights/New Data Gleevec Friday, May 11 -- Signal...


New Data Suggest Novartis Drug Effective In Rare Form of Gastrointestinal...: Newspaper article from: Biotech Week May 23, 2001 700+ words
...signal transduction inhibitor, Gleevec[TM] (imatinib mesylate...Clinical Oncology (ASCO) in San Francisco, California, on May 13, 2001. Data on the activity of Gleevec in a rare form of gastrointestinal...Administration (FDA) approved Gleevec on May 10, 2001, as an oral...


New Data Suggest Novartis Drug Gleevec(TM) (Formerly STI571) Effective In Rare...: Press release article from: PR Newswire May 13, 2001 700+ words
...Myeloid Leukemia (CML) SAN FRANCISCO, May 13 /PRNewswire...data on the activity of Gleevec(TM) (imatinib mesylate...Oncology (ASCO) in San Francisco, California. Also during...potential activity of Gleevec in CML and GIST will...


STUDY OF SPRYCEL(R) (DASATINIB) OR 800 MG OF GLEEVEC(R)* (IMATINIB MESYLATE)...: Press release article from: PR Newswire December 11, 2006 700+ words
...between SPRYCEL and high-dose Gleevec in progression-free survival...resistant to lower doses of Gleevec," said Neil Shah, MD...University of California, San Francisco. Study Design and Results...resistance to 400-600 mg doses of Gleevec. Patients were randomized...


Gleevec* leads to longest survival reported for patients with life-threatening...: News wire article from: The America's Intelligence Wire December 11, 2008 700+ words
...Oncology's annual meeting in San Francisco this week showed that seven...initiated treatment with (Pr)Gleevec* (imatinib mesylate) are...patients who continue taking Gleevec* achieved a major molecular...survivor from Montreal . "But Gleevec gave me my life back and it...


Power3 Medical Files Application with U.S. Patent Office for Test to Determine...: Press release article from: Business Wire April 24, 2006 700+ words
...resistance to - imatinib mesylate (Gleevec(R)). Power3 also said...by enhancing the ability of Gleevec(R) to bind to the BCR...Congress of OncoProteomics in San Francisco (www.selectbiosciences...and overcoming resistance to Gleevec in the treatment of CML...


Gleevec, the cancer drug, stars in clinical trials.: News wire article from: The America's Intelligence Wire December 3, 2008 700+ words
...weeks of starting daily doses of imatinib, better known as Gleevec. The pill has saved many thousands of lives since it became...disorders. Researchers at the University of California at San Francisco recently showed how imatinib could reverse diabetes in mice...


Protein Inhibitor Targets Chronic Myeloid Leukemia And Gastrointestinal Stromal...: Newspaper article from: Drug Week April 20, 2001 700+ words
...Glivec to treat GIST patients began last year and will be reported on at the American Society of Clinical Oncology meeting in San Francisco, California on May 13, 2001. "While it's too early to comment on the success of Glivec on GIST patients, we are optimistic...

For more facts and information, see all results

The AccessMyLibrary advertising network includes: